Local
Pro-life orgs urge transparency, accuracy in FDA abortion drug review
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Source: Just the News

Francis said the FDA's safety review will be worthless if it relies on inadequate and incomplete data sets.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Just the News



